Экспрессия маркерного антигена мелкоклеточного рака легких — ганглиозида FucGM1: иммуноморфологическое и иммунохимическое исследование с помощью моноклональных антител

Список литературы

1. Аврова Н. Ф. Структура и функции ганглиозидов. //Нейрохимия.-198 9.-Т.8.-№ 3.-С.433−451.
2. Гусева М.Р. Изменения органа зрения у детей при общих заболеваниях КОФ.-2001.-Т.2.- № 4.-С.14−24.
3. Дятловицкая Э. В. Ганглиозиды и антитела к ганглиозидам сыворотки крови.//Биохимия-1992.-Т.57.~ № 7.-С.1004−1010.
4. Дятловицкая Э. В. Ганглиозидный «шеддинг» опухолевых клеток.//ДАН.-198 3.-Т.271.-№ 6.-С.1511−1513.
5. Дятловицкая Э. В., Текиева Е. А., Леменовская А. Ф., Сомова О. Г., Бергельсон Л. Д. Ганглиозиды GM3 и GD3 в опухолях желудка и молочной железы человека.//Биохимия.-1995.-№ 3.-С.560−564.
6. Ерышев О.Ф., Аркадьев В. В. Современные тенденции фармакотерапии больных алкогольной зависимостью.//Журнал «Психиатрия и психофармакотерапия». -2003.-Т.05.-№ 4.-С.7−9.
7. Фукс Б.Б., Аврова Н. Ф., Ванько Л. В., Зарайский Е.И.,. и др. Получение и исследование моноклональных антител против некоторых ганглиозидов.//Бюллетень экспериментальной биологии и медицины.-1986.-№ 1.-С.66−68.
8. Abbadi М El, Seyfried Т N, Yates A J, Orosz С and Lee МС. Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse. //British Journal of Cancer.-2001.-V.85-P.285−292.
9. Acquotti D. fie Sonnino S. Use of nuclear magnetic resonance spectroscopy in evaluation of ganglioside structure, conformation and dynamics.//Method Enzyology.-2000.-V.312.-P.247−272.
10. Bassi Rosaria, Viani Paola, Tettamanti Guido, Riboni Laura. Effect of GM3 ganglioside on endothelin-mediated signal transduction in C6 glioma cells- Joint Symposia I.B.C.S.Y.// Biochemical S.-2000.-P.101−104 .
11. Bast R.C. Editorial: Progress in radioimmunotherapy. //New Engl.J.Med.-1993.-P.1266.
12. Bast R.C., De Fabritiis, Lipton J.. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement// Cancer Res.-1985.-V.45.-P.499−503.
13. Bast R.C., Feeney M., Lazarus H.. Reactivity of a monoclonal antibody with human ovarian carcinoma. //J. Clin. Invest.-198l.-V.68.-№ 5.-P.1331−1337.
14. Bernardi A., Arosio D. and Sonnino S. Mimicking gangliosides by design: mimics of GM1 headgroup. //Neurochem.-2002.-V.27.-P.539−545.
15. Bernardi A., Carrettoni L., Grosso Ciponte A., Monti D. and Sonnino S. Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: replacement of the sialic acid moiety.//Bioorg.-2000.-Med. Chem. Letters.-V.10.-P.2197−2200.
16. Brocca P., Bernardi A., Raimondi, L. and Sonnino, S. Modeling Ganglioside Headgroups by Conformational Analysis and Molecular Dynamics.//Glycoconjugate J.-2000.-V.17.-P.289−299.
17. Brockhaus M., Magnani J.C., Blaszczyk M., Stepkevski Z., Koprowski H., Karlsson K.A., Larsson G., Ginsburg V. Monoclonal antibodies directed against the human Le blood group antigen.//Biol. Chem.-V.256.-P.12 223−13 225.
18. Brockhausen I., Lehotay M., Yang J.-M. et.al. Glycoprotein biosynthesis in porcine aortic endothelial cells and changes in the apoptotic cell population. //Glycobiology.-2002.-V.12(1).-P.33−45.
19. Carey D. Cancer Therapy Despite Therapeutic Benefit -Physicians and patients alike are the accumulation of certain fats (gangliosides) in the brain and othertishue.//Cancer. -2004.-3(30).-P.125−136.
20. Chen X.-P., Enioutina E.Y. and Daynis R.A. The control of IL-4 gene expression in activated murine T lymphocytes: a novel rol for neu-1 sialidase.// J. Immunol.-1997.-V.158.-P.3070−3080.
21. Cheresh D.A., Honsir C. J., Statfileno L. K et.al. Disialoganglioside G03 on human melanoma serves as a relevant targets antigen for monoclonal antibody-mediated tumor cytolys is.//PNAS USA.-1985.- V.82.-P.5155−5159.
22. Chia D., Terasari P.I., Suyama N. et.al.Use of monoclonal antibodies to sialylated Le and sialylated Le for serological tests of cancer.//Cancer Res.-1985.-V.45.-P.435−437.
23. Chigorno, V., Palestini, P., Sciannamblo, M. T et.al. Evidence that ganglioside domains are distinct from and caveolae in MDCK and human fibroblast cells in culture. //Eur. J. Biochem.- 2000.-V.267.-P.4187−4197.
24. Coombes R.Ch., Buckeman R., Ferrester J.A. et. al//. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. //Cancer Res.-1986.- V.46.-P.4217−4220.
25. Delvillano B, Zuzawski W. The carboghydrat antigenic determinant 19−9 (CA 19−9):a monoclonal antibody defined tumor marker.//Immunodiagnostika.-1983.-P.269−282.
26. Dettke M., Pá G.-lfi, and Loibner H. Activation-dependent expression of the blood grouprelated Lewis Y antigen on peripheral blood granulocytes J. Leukoc.//Biol.-2000.-V.68.-№ 4.-P.511−514.
27. Dippold W.G., Dienes H.P., Knuth A. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. //Cancer Res.-1985.-V.45.-P.3699−3705.
28. Dippold W.G., Knuth A, Buschenfeide K. Ynhibition of Human melanoma Cell Growth in vitro by monoclonal anti-GD3-ganglioside antibody.//Cancer Research.- 1984.-V.44.-P.806−810.
29. Dohi-T, Hashiguchi-M. Fucosyltransferase producing sialyl Le (a) and sialyl Le (x) carbohydrate antigen in gastrointestinal cancer.//Nippon-Rinsho.-1995.-V.53.-№ 7.-P.1781−1785.
30. Douillard J.Y., Lehur P.A., Aillet G. Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with specificity for tumors of the gastrointestinal tract. //Cancer Res.-1986.-V.46.-P.4221−4224.
31. Drivsholm L. Vangsted A. PallesenT. Fucosyl-GMl in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase. //Ann-Oncol.-1994.-V.5.-№ 7.-P.623−626.
32. Engval E., Porlman P. Enzyme-linked immunosorbent assay (ELISA), quantitative assay for immunoglobulin G.//Immunochem.-1971.-V.8.-P.871−874.
33. Epenetos A.A., Kosmas C. Monoclonal antibodies for imaging and theray. //Brit.I.Cancer.-198 9.-V.59.-№ 2.-P.152−155.
34. Fazecas de St. Groth, S., Scheidegger D. Production of monoclonal antibody. Strategy and tactics. //Immunol. Meth.-1980.-V.35.-P.1−21.
35. Feld K., Gerrit D., Sacman N. Prognostic factors for small cell carcinoma of the lung. Evr. J. Clin. //Oncol.- 1988.-V.42.-P.353−355.
36. Fredman P., Brezicka THolmgrenJ. Binding specificity of monoclonal antibodies to ganglioside, FucGMl.//Biochimica et Biophysica acta.-1986.-V.875.-P.316−323.
37. Fucushi V, Hakomori S, Nudelman E, Cochran N.
38. Novel fucolipids accumulating in human adenocarcinoma. 11
39. Selective isolation of hibridoma antibodies thatdifferentially recognize mono, di and tri fucosylated type2 chain. J.//Biol. Chem.-1984.-V.259.-№ 7.-P.4681−4685.
40. Fukushi J., Nudelman E., Levery S.B. Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). //Biol. Chem.-1984.-V.259.-P.10 511−10 517.
41. Guegan C. and Przedborski S. Programmed cell death in amyotrophic lateral sclerosis.//J. Clin. Invest.-January 15, 2003.-V.111.-«2.-P.153−161.
42. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. //PNAS.-2002.-V.99.- № 16.-P.10 231−10 233.
43. Hakomori S. Glycosylation defining cancer malignancy.//J. Biol. Chem.-2002.-V.259.-P.4672−4680.
44. Hakomori S. Gangliozids configuration durind cancermalignancy: New wine in an old bottle.//J. Natl. Cancer Inst.-2002.-V.71.-P.231−251.
45. Hakomori S. Tumor-associated glycolipid antigens detined by monoclonal antibodies.//Bull Canar.-1983.-V.70.- № 2.-P.118−126.
46. Hakomori S.-i. Inaugural Article: The glycosynapse. //PNAS.-2002.-V.99.-№l.-P.225 -232.
47. Hakomori S.I. Tumor-associated glycolipid their metabolism and organization. //Chemistry and Physics of lipids.-1986.-V.42.-P.209−231.
48. Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. //PNAS.-2002.-V.99.-№.16.-P.10 231−10 233.
49. Hakomori S-I., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers.//"J. Nat. Cancer Inst.».-1983.-V.71.-№ 2.-P.231−251.
50. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. //Adv. Cancer Res.-1989.-V.52.-P.257−331
51. Hakomori S. Kannagi R. Glycoshingolipids as tumor-associated and differentiation markers.//J. Natl. Cancer Inst.-1983.-V.71.-P.231−251.
52. Hanai N.. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.//Cancer Res.-1986.-V.46.-P.4438−44 43.
53. Hayashi I., Amano H., Yoshida S.et.al. Suppressed Angiogenesis in Kininogen-Deficiencies Lab.//Invest.-2002.-V.82.-№ 7.-P.871−880.
54. Herr Ingrid, Debatin B. Cellular Klaus-Michael stress response and apoptosis in cancer therapy.//Blood.- 2001.-V.98.-P.2603−2614.
55. Hiraishi K, Suzuki K, Hakomori S and Adachi M Le (y). Antigen expression is correlated with apoptosis (programmed cell death).//Glycobiology.-1993.-V.3.1. P.381−390.
56. Hiraiwa N. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.//Cancer Res.-1990.-V.50.-P.5497−5503.
57. Hirashima, G. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies.//J. Immunol.-1990.- V.145.-P.224−232.
58. Hirota M., Fukushima K., Terasaki P.J.. Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies. //Cancer Res.1985.-V.45.-P.6453−64 56.
59. Houghton A.N., Scheinberg D.A. A Heteroclitic Peptide Vaccine Induces CD8+ T-Cell Responses to CD20.//Seminars in Oncology.-1986.-V.13.-№ 2.-P.165−179.
60. Houghton A.N. Gangliosides in the oncological studies.//Oncology.-1985.-V.12.-№ 3.-P.24.
61. Iliopoulos D., Ernst C., Steplewski Z. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3gangliosides.//Journal Of The National Cancer Institute.-2004.-V.81.-P.440−444.
62. Inaudi P., Pasqui G., Torre G.C. et.al. CA 125 and CA 19−9 in peritoneal, cyst and amniotic fluids.//Med. Oncol, and Tumor Abarmacofher.-1988.- V.5.- № 4.-P.233−238.
63. Irie R.F., Morton D.L. Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2 //Proc. Natl. Acad. Sci. US.-1986.-V.83.-№ 22.-P.8 694−8698.
64. Iwai K., Ishikura H., Kaji M.,. Importance of E-selectin (ELAM-1) and sialyl Lewis A in the adhesion of pancreatic carcinoma cells to activated endothelium.//Int. J. Cancer.-1993.- V.54.-P.972−977.
65. Kanda N., Nakai K., and Watanabe S. Gangliosides GDlb, GTlb, and GQlb Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production: the Inhibition of Adenylate Cyclase.//J. Invest. Dermatol.-2001.-V.117.-№ 2.-P.284−293.
66. Kaneko T. Preparation of mouse-human chimeric antibody to an embryonic carbohydrate antigen, Lewis Y. //J. Biochem.-1993.-V.113.-P.114−117.
67. Kawashima I. H. Ozawa, M. Kotani. Characterizationof ganglioside expression in human melanoma cells: Immunological and biochemical analysis.//J.Biochem.-1993.-V.114.-P.186−193.
68. Kawashima I. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies.//Brain Res.-1996,-V.732.-P.75−86.
69. Kawashima I. Identification of HLA-A3-restricted Cytotoxic T Lymphocyte Epitopes from Carcinoembryonic Antigen and HER-2/neu by Primary in Vitro Immunization with Peptide-pulsed Dendritic Cells.//J.Biochem.-1993.-V.114.-P.186−193.
70. Kawashima I. Ganglioside in human melanoma cells.//J.Biochem.-1992.-V.113.-P.123−125.
71. Kawashima I. Telomerase-Specific Replication-Selective Virotherapy for Human Cancer.//Brain Res.-1996.-V.732.-P. 75−86.
72. Kohler G., Milstein C. Continious cultures of fused cells secreting antibody of predefined specificity. //Nature.-1975.-V.256.- № 55.- P.495−497.
73. Koprowski H., Steplewski Z., Mitchel K et. al Colorectal carcinoma antigens detected by hybridoma antibodies.//Cell Genet.- 1979.-V.5.-P.957−972.
74. Kotani M. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex.//Brain Res.-1995.-V.700.-P.40−58.
75. Kotani M. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides.//Biochim. Biophys. Acta.-1992.- V.1117.-P.97−103.
76. Kotani M, Hosoya H, Kubo H, et.al.Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts.//CellStruct.Funct.-l994,Apr.-V.19(2).-P.81.
77. Kotani M, Kawashiraa I, Ozawa H et.al.Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies.// Glycobiology.-1993- V.3.-P.137−146.
78. Kotani K., Kotani K., Hara K., et.al.Normal Activation of P70 S6 Kinase by Insulin in Cells Overexpressing Dominant Negative 85-kDa Subunit of Phosphoinositide 3-Kinase.// Biochemical and Biophysical Research Communications.-1995 .-V.208.- P.735−741.
79. KotaniY., Matsuda S., Sakanaka, M.et.al. Prosaposin facilitates sciatic nerve regeneration in vivo.// J. Neurochem.-1996.-V.66.-P.2019−2025.
80. Kotani, M. Immunohistocehmical localization of minor gangliosides in the rat central nervous system. //Glycobiology.-1994.-V.4.-P.855−8 65
81. Kubo, H. Differential distribution of ganglioside GM1 and sulfatide during the development of Xenopus embryos.//Develop.Growth.Differ.-1995.-V.37.-P.243−255.
82. Larson S.M. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy, nucl. //Med.-1985.-V.26-P.538−545
83. Leahy J.L. Vanderkerkhove K. M. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. // Endocrinology.-1990 .-V.126, N3.-P.1593−1598
84. Ledermann J. A., Begent R.H.J., Keep P.A. et.al. The human antibody response to radiolarelled antibodies for tunour therapy. //6th Int. Congr. Immunol., Toronto, 1. July 6−11, 1986.-P.545.
85. Loberto N, Prioni S, Ottico E. et.al. The adesion protein TAG-1 has a ganglioside environment in the sphingolipid enriched membrane domains of neuronal cells in culture. //J. Neurochem.- 2003.- V.85.-P.224−233.
86. Mü J., Burg M., Mö B, et.al. Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally 2−6-sialylated neolacto-series gangliosides.//Glycobiology Abstracts: Müathing.-2001.-V.8.-P.485
87. Marechal F., Berthiot G., Deltour G. Sezam levels of CA-50, CA-125, CA15.3, enolas and carcino-embryonic antigen in non neoplastic diseases of the lung. //Anticancer Res.- 1988.-V.8, № 4.-P.677−680.
88. Martino S, Cavalieri C., Emiliani C. et.al. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from a Tay-Sachs disease animal model. //Neurochem. Res.- 2002.-V.2.-P.793−800.
89. Martino S, Emiliani C, Tancini B. et.al. Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy.//J Biol Chem.- 2002.-V.277.- P.20 177−20 184.
90. Masserini M, Palestini P, Pitto M, Chigorno V and Sonnino S Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systems. //Methods in Molecular Biology.-2002.-V.199.-P.17−27.
91. Masserini M., Ravasi D. and Sonnino S. Role of glycosphingolipids in formation and function of membrane microdomains. //Trends Glycosc. Glycotech.- 2001.-V.13.-P.239−250.
92. Maura N. Dickler, Govindaswami Ragupathi, Nancy X. Liu et.al. Grant Immunogenicity of a Fucosyl-GMl
93. Keyhole Limpet Hemocyanin Conjugate Vaccine in Patients with Small Cell Lung. //Cancer Clinical Cancer Research.- October 1999.- V.5.- P.2773−2779
94. Mauri L, Prioni S, Loberto N. et.al. Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactions. //Glycoconjugate J.- 2003.- in press.
95. Mauri L, Valsecchi M, Casellato R. et.al. Procedure for the separation of the GM2 ganglioside species with different ceramide structures by flash reversed-phase silica gel liquid chromatography. //J. Chromatog B.- 2003.- in press.
96. Miljan E. A., Meuillet E. J., Mania-Farnell B. et.al. Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides. //J. Biol. Chem.- March 22, 2002.- V.277,№ 12.-P.10 108 -10 113.
97. Minasian-LM, Yao-TJ, Steffens-TA. et.al.A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma. //Cancer.-1995 May 1.- V.75,№ 9.- P.2251−2257.
98. Miyake M.. Generation of two murine monoclonal antibodies that can discriminate N-acetyl neuraminic acid residues of GM2 ganglioside. //Cancer Res.- 1988.-V.48.- P.6154−6160.
99. Miyake M Adachi M, Taki T, et.al.Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.// Cancer Research.- 2002 .-V.56.- .P.1751−1755.
100. Miyake M. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors.//Cancer.-1990.- V.65.-P.499−505.
101. Miyake Y., Nakamura S., Kozutsumi Y. Dual roles of sphingolipids in signaling of the escape from and onset of apoptosis in a mouse cytotoxic T-cell line, CTLL-2.//J. Biol. Chem.-1996.-V.271.-P.1255−1257.
102. Mulchine J.L., Cuttitta F., Bibro M. Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy.//J. Immunol.- 1983.- V. 131.- P.497−502.
103. Munck-Wikland E., Kuylenstierna R., Wahren B. Prognostic and predictive markers for cancer and dysplasias of the head and neck //Cancer.- 1988.-V. 62.-P.2281−2286.
104. NaKane P, Hiroshi Nakane- Francis JHeis et.al. Gene Transfer of Endothelial Nitric Oxide Synthase Reduces Angiotensin II-Induced Endothelial Dysfunction Hypertension. // J. Biol. Chem.- 2000.-V.35.-595.-P.7−9.
105. Nakane P.K., Kawaoi A. Enzyme-labeled antibodies preparation and application for the localization of antigens.//J.Histochem.Cytochem.-1974.-V.22.-P.1084−1091.
106. Nilsson 0., Brezicka T., Holmgren. Detection of gangliosideantigen associated with small cell. carcinomas using monoclonal antibodies directed agaj Fucosyl-GMl.//Cancer Research.-1986.-V.48.-P.14 03−14 07.
107. Nojiri Hisao, PhD, Yamana Hideaki, MD, Shirouzu Genzan, MD. et.al. Glycotherapy for cancer: remodeling of ganglioside pattern as an effective approach for cancer therapy. //Cancer Detection and Prevention.-2002.-V.26(2).-P.75−76.
108. North P. E., Waner M., Mizeracki A. et.al. Jr A Unique Microvascular Phenotype Shared by Juvenile Hemangiomas and Human Placenta Arch Dermatol.// Cancer.
109. May 1, 2001.-V.137(5)P.559 570.
110. Ogata S., Ho I., Chen A. T et.al. umor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. //Cancer-Res.- 1995 May 1.-V.55 (9) .- P.1869−74.
111. Ohta S., Tsukamoto H., Watanabe K. et.al. Tumor-associated glycoantigen, sialyl Lewis (a) as a target for bispecific antibody-directed adoptive tumor immunotherapy. //Immunol-Lett.-1995 Jan.-V.44(1).-P.35−40
112. Ono M., Handa K., Sonnino S. et.al. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: co-expression of GM3 and CD9 is essential in down-regulation of tumor cell motility and malignancy. //Biochemistry.- 2001.- V.40.- P.6414−6421.
113. Ottico E, Prinetti A, Prioni S Dy et.al.
114. Namics of lipid membrane domains in cultured cells.// J. Lipid Res.- 2003.- in press.
115. Posmus P.E., CJ Hirschler-Schulte, BS Hylkema, and RW Meyer. Mechanical ventilation for acute postoperative respiratory failure after surgery for bronchial carcinoma. //Thorax.- May 1985.-V.40.-P. 387 390.
116. Posmus P.E., Hirschler-Schulte T.J.W., De Leij L. Mechanical ventilation for acute postoperative respiratory failure after surgery for bronchial carcinoma //Cancer.- 1986.- V.57.- P.60−63.
117. Prinetti A., Chigorno V., Prioni S. et.al. Changesin the lipid turnover, composition and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. //J. Biol. Chem.- 2001.-V.276.- P.21 136−21 145.
118. Prinetti A., Marano N., Prioni S. et.al. Association of Src-family protein tyrosine kinases with sphingolipids in rat cerebellar granule cells differentiated in culture. //Glycoconjugate J.-2000.-V.17.- P.223−232.
119. Prinetti, A., Chigorno, V., Tettamanti, G. and Sonnino, S. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture: a compositional study. //J. Biol. Chem.- 2000.-V.275.-P.11 658−11 665.
120. Prinetti, A., Basso, L., Appierto, V. et.al. Altered sphingolipid metabolism in N-(4-hydroxyphenyl)retinamide-resistant A2780 human ovarian carcinoma cells. //J.Biol.Chem.- 2003.-V.278.-P.5574−5583.
121. Prioni S., Loberto N., Prinetti A.et.al. Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GNU and gonadotropin-releasing hormone-secreting GT1−7 neuronal cells. //Neurochem. Res.- 2002.-V.27.- P.831−840.
122. Ranes M.K., El-Abbadi M., Manfredi M.G.et.al. Nbutyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. //British Journal of Cancer.- 2001.-V.84.- P.1107−1114.
123. Reisfeld Ralph A., Cheresh David A. Human tumor antigens.//Immunol. -1987.- V.40.- P.323−377.
124. Rizzo A.M., Rossi F., Guerra A. et.al. Exogenous sphingosine is taken up and metabolised by Xenopus laevis embryos grown in Petri dishes. //Bioscience Rep.-2001.-In press
125. Rizzo AM, Berra B, Rossi F. et.al. Structure of the main ganglioside from the brain of Xenopus Laevis. //Glycoconjugate J.-2002.-V.19.- P.53−57.
126. Rubenstein K.F., Schneidein K.E., Huisjen J., Ullman E.F. Mechanism by immunoassay. New Immunochemical technique Biochem. //Biophis. Res. Commun.- 1972.-V.47.- P.846−851.
127. A. H. Rubenstein, PM Blix, D.L. Horwitz, D.F. Steiner. Cell Cycle Regulation of Menin Expression. //Diabetes.- 1977.-V.26.-P. 22−29.
128. Satoh, M-Ito, A-Nojiri et.al. GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. //INTERNATIONAL JOURNAL OF ONCOLOGY.- OCT 2001.-V.19(4).-P.723−731.
129. Schultz G., Cheresh D.A., Varki N.M. et. al Detection of ganglioside GD2 in tumor tissue and sera of neuroblastoma patients. //Cancer Res.- 1984.-V.44.-P.5914−5920.
130. Sciannamblo M., Chigorno V., Passi A. et.al. Changes of the ganglioside pattern and content in human fibroblasts by high density cell population subculture progression. //Glycoconjugate J.- 2002.-V.19.- P.181−186.
131. Sears H.F., Herlyn D., Steplewsli Z. Identificationof the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19−9 in the sera of patients as a mucin. //Cancer Res.- 1985.-V. 45.-P.5910−5913.
132. Senger Donald R., Claffey Kevin P., Benes Julie E. et. al Angiogenesis promoted by vascular endothelialgrowth factor: Regulation through
133. Seppala M., Taylor R. N., Koistinen H. et. al Glycodelin: A Major Lipocalin Protein of the Reproductive Axis with Diverse Actions in Cell Recognition and Differentiation Endocr. //Rev.- August 1, 2002.-V.23(4).- P.401 430.
134. Seppo Antti, Matani Parul, Sharrow Mary and Tiemeyer Michael. Induction of neuron-specific glycosylation by Tollo/Toll-8, a Drosophila Toll-like receptor expressed in non-neural cells. //Development.-2003.-V.130.- P.1439−1448.
135. Shamshiev A., Donda A., Prigozy T.I.et.al.The Pa T cells response to self-glycosphingolipids shows a novel mechanism of CDlb loading and requirement for complex oligosaccharides. //Immunity.- 2000.-V.13.-P.255−264.
136. Shitara, K. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. //Cancer Res.-1987.-V.47.-P.1267−1272.
137. Shurin G. V., Shurin M. R., Bykovskaia S. A et.al. Neuroblastoma-derived Gangliosides Inhibit Dendritic Cell Generation and Function. //Cancer Research.-January 1, 2001.-V.61.- P.363−369.
138. Sieri K., Kiruchi Y., Uesato K., Kato K Yncreased sezam CA 125 levels daring the first trimester ofpregnansy. //Acta obstet. gynaecol. Scand.- 1986.-V.65.-P.583−585.
139. Smets Lou A. Tumor cell curfasecarbohydrates: genetic control and phenotypic implications.//"Membranes Tumor Growth. Proc. Int. workshop, Rome, June 14−18, 1982″. Amsterdam e.a.- 1982.- P.139−147.
140. Sonnino S. Forward. Special issue on sphingolipids dedicated to Professor Guido Tettamanti, Neurochem. //Res.- 2002.-V.27.- P.537−538.
141. Sonnino S. and Chigorno V. Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissue and neuronal cell cultures. //Biochim. Biophys.- 2000.- V.469.- P.63−77.
142. Sonnino, S. and Tettamanti, G. (Guest Editors). Glycosphingolipids and membrane domains. //Glycoconjugate J.- 2000.-V.17.- P.141.
143. Sonnino, S., Chigorno, V. and Tettamanti G. Preparation of radioactive gangliosides, 3H. or [14C] isotopically labeled at the oligosaccharide or ceramide moieties. //Method Enzym.- 2000.-V.311.- P.639−656.
144. Steplewsri Z., Spira G., Blaszczyr M. et.al. Scharff Isolation and characterization of anti-monosialoganglioside monoclonal antibody IS-9 class-switch variants. //PNAS.- 1985. V.82.-P.8653−8657.
145. Suikkari A., Koivisto U., Rutanen Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein //E.Ibid.-1988.-V.66.-P.266−272.
146. Sun P., Wang X.Q., Lopatka K., Bangash S., and Paller A. S. Ganglioside Loss Promotes Survival Primarily by Activating Integrin-Linked Kinase/Akt Without Phosphoinositide 3-OH Kinase Signaling //J. Invest. Dermatol.- July 1, 2002.-V.119(1).-P.107−117.
147. Sung-C.C., Pearl D.K., Coons S.W., Scheithauer B.W., Johnson P.C., Yates A.J. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. //Cancer.-1994 Dec l.-V.74(11).-P.3010−22.
148. Tai T. Cell type-specific expression of ganglioside antigens in the central nervous system. Pure and Appl. //Chem.- 1997.-V.69.- P.1903−1910.
149. Tai, T. Head, Department of Tumor Immunology. //The Tokyo Metropolitan Institute of Medical Science.-1999.-P.34−37.
150. Tai, T. Generation of a monoclonal antibody specific for ganglioside GM4. //PudMed.-1993.-P.123−141.
151. Takada, A..: Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. //Biochem. Biophys. Res. Commun.-1991.-V.179.-P.713−719.
152. Takada A. Epstein-Barr Virus and Cancer. //Clin Cancer Res.-2004.-V.10.-P.803.
153. Takada A. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. //Cancer Res.-1993.-V.53.-P.354−361.
154. Takada, A. Therefore, antibodies against carbohydrate antigens of donor kidney can be presented in the recipient’s blood //Nature.1994.—V.372.-P.7.
155. Tockman M., Gupta R.K., Myers J.D. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. //J. Clin. Oncol.- 1988.-V. 6(11).-P.1685−1693.
156. Tong A.W., Lee J., Stone M.J. Quantitative Epstein-Barr Virus DNA Analysis and Detection of Gene Promoter Hypermethylation in Nasopharyngeal (NP) Brushing Samples from Patients with NP Carcinoma//Cancer Res.- 1984.-V.44.- P.4987−4992.
157. Treleaven J. G., Gibson F. M., Ugelstad J. et.al.Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. J., Philip T.. //Lancet.- 1984.- p.70−73.
158. Tsuji, T. Prognostic Significance of CEA, CA 19−9 and CA 72−4 Preoperative Serum Levels in Gastric Carcinoma//Anticancer Res.- 1989.-V.9.- P.327−340.
159. Ugur 0, Scott A. M, Kostakoglu L, et.al.Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model. //Nucl-Med-Biol.- 1995 Jan.-V.22(1).- P.87−93.
160. Valiente 0., Mauri L., Casellato R.,. Fernandez L. E and Sonnino S. The preparation of deacetyl-, lyso-and deacetyl-lyso-GM3 by selective alkaline hydrolysis of GM3 ganglioside. //J. Lipid Res.- 2001.-V.42.-P.1318−1324.
161. Vangsted Annette, Drivsholm Lars, Andersen Elo, Pallesen Tina, Zeuthen Jesper, Wallin Hakan, New Serum Markers for Small-Cell Lung Cancer I. The Ganglioside Fucosyl-GM (l). //Published in Cancer Detection and Prevention.- 1994 .-V.18 (3).-P.221−230.
162. Vangsted A.J. Serological tumor markers for small cell lung cancer and their therapeutic implications. //APMIS.-1994 Aug.-V.102(8) .-P.561−80
163. Vangsted A.J. Correlation with bladder cancer risk.
164. Cancer Res.- 1991.-V.51.-P.2762.
165. Wang X.Q., Sun P. and Paller A. S. Ganglioside GM3 Inhibits Matrix Metalloproteinase-9Activation and Disrupts Its Association with Integrin. //J. Biol. Chem.- July 11, 2003.-V.278(28).- P.25 591 25 599.
166. Wang X.Q., Sun P. and Paller A. S. Ganglioside Induces Caveolin-1 Redistribution and Interaction with the Epidermal Growth Factor Receptor. //J. Biol. Chem.-December 6, 2002.-V.277(49).-P.47 028−47 034.
167. Wang X.Q., Sun P. and Paller A. S. Ganglioside Modulation Regulates Epithelial Cell Adhesion and Spreading via Ganglioside-specific Effects on Signaling. //J. Biol. Chem.- October 25, 2002.-V.277(43).- P.40 410−40 419.
168. Wang X.Q., Sun P. and Paller A. S. Inhibition of Integrin-linked Kinase/Protein Kinase B/Akt Signaling. MECHANISM FOR GANGLIOSIDE-INDUCED APOPTOSIS. //J. Biol. Chem.- November 30, 2001.-V.276(48).-P.44 504−44 511.
169. Watari, S. Application of liposomes to generation of monoclonal antibody to glycosphingolipid: Production of monoclonal antibody to GgOse4Cer. //J. Biochem.-1987 .- V. 102.- P.59−67.
170. Watty A. and Burden S. J. MuSK Glycosylation Restrains
171. MuSK Activation and Acetylcholine Receptor Clustering. //
172. J. Biol. Chem.-December 27,2002. V. 277(52).- P.5 045 750 462.
173. Weiss M., Hettmer S., Smith P., and Ladisch S. Inhibition of Melanoma Tumor Growth by a Novel Inhibitor of Glucosylceramide Synthase.//Cancer Res.-July 1,2003,1. V.63(13).- P.3654−3658.
174. Wilkins J.R., D’Ercole A.J. Affinity-labeled plasma somatomedin-C/Ynsulinlike growth factor 1 binding proteins. //J. Clin. Chim. Invest.- 1985.- V.75(4).-P.1350−1358.
175. Yamanda-T., Haniuda-M., Iida-F., Kannagi-R. Immunohistochemical expression of sialyl-Lewis antigens in lung cancer. //Nippon-Rinsho.- 1995 Jul.- V.53(7).-P.1776−1780.
176. Yamashina I. Carbohydrate-directed monoclonal antibodies and their use in cancer diagnosis. //Published in Cancer Detection and Prevention.-1995.-V.19(1).-P.4.
177. Zecca L., Costi P., Mecacci C et.al.Interaction of human substantia nigra neuromelanin with lipids and peptides. //J. Neurochem.- 2000.-V.74.-P.1758−1765.